These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16918244)

  • 1. Inhibition of cellular respiration by doxorubicin.
    Tao Z; Withers HG; Penefsky HS; Goodisman J; Souid AK
    Chem Res Toxicol; 2006 Aug; 19(8):1051-8. PubMed ID: 16918244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dactinomycin impairs cellular respiration and reduces accompanying ATP formation.
    Tao Z; Ahmad SS; Penefsky HS; Goodisman J; Souid AK
    Mol Pharm; 2006; 3(6):762-72. PubMed ID: 17140264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cellular respiration in cells exposed to doxorubicin.
    Souid AK; Penefsky HS; Sadowitz PD; Toms B
    Mol Pharm; 2006; 3(3):307-21. PubMed ID: 16749863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase activation by anticancer drugs: the caspase storm.
    Tao Z; Goodisman J; Penefsky HS; Souid AK
    Mol Pharm; 2007; 4(4):583-95. PubMed ID: 17439154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cisplatin on mitochondrial function in Jurkat cells.
    Tacka KA; Dabrowiak JC; Goodisman J; Penefsky HS; Souid AK
    Chem Res Toxicol; 2004 Aug; 17(8):1102-11. PubMed ID: 15310242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-DNA adducts induce a non-topoisomerase II-mediated form of cell death.
    Swift LP; Rephaeli A; Nudelman A; Phillips DR; Cutts SM
    Cancer Res; 2006 May; 66(9):4863-71. PubMed ID: 16651442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells.
    Kik K; Wasowska-Lukawska M; Oszczapowicz I; Szmigiero L
    Anticancer Res; 2009 Apr; 29(4):1429-33. PubMed ID: 19414398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between topoisomerase II-DNA cleavable complexes, apoptosis and cytotoxic activity of anthracyclines in human cervix carcinoma cells.
    Gruber BM; Anuszewska EL; Bubko I; Gozdzik A; Priebe W; Fokt I
    Anticancer Res; 2005; 25(3B):2193-8. PubMed ID: 16158963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate effects of anticancer drugs on mitochondrial oxygen consumption.
    Souid AK; Tacka KA; Galvan KA; Penefsky HS
    Biochem Pharmacol; 2003 Sep; 66(6):977-87. PubMed ID: 12963484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoids inhibit cellular respiration of human oral cancer cells.
    Whyte DA; Al-Hammadi S; Balhaj G; Brown OM; Penefsky HS; Souid AK
    Pharmacology; 2010; 85(6):328-35. PubMed ID: 20516734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-ITdU-mediated nanoirradiation of DNA efficiently induces cell kill in HL60 leukemia cells and in doxorubicin-, beta-, or gamma-radiation-resistant cell lines.
    Reske SN; Deisenhofer S; Glatting G; Zlatopolskiy BD; Morgenroth A; Vogg AT; Buck AK; Friesen C
    J Nucl Med; 2007 Jun; 48(6):1000-7. PubMed ID: 17504875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria.
    Clementi ME; Giardina B; Di Stasio E; Mordente A; Misiti F
    Anticancer Res; 2003; 23(3B):2445-50. PubMed ID: 12894526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
    Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
    Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis repressor with caspase recruitment domain contributes to chemotherapy resistance by abolishing mitochondrial fission mediated by dynamin-related protein-1.
    Wang JX; Li Q; Li PF
    Cancer Res; 2009 Jan; 69(2):492-500. PubMed ID: 19147562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative measure of cytotoxicity of anticancer drugs and other agents.
    Tao Z; Jones E; Goodisman J; Souid AK
    Anal Biochem; 2008 Oct; 381(1):43-52. PubMed ID: 18602881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of doxorubicin-induced apoptosis in vivo by 2-deoxy-D-glucose.
    Thakkar NS; Potten CS
    Cancer Res; 1993 May; 53(9):2057-60. PubMed ID: 8481907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.
    Pereira da Silva AP; El-Bacha T; Kyaw N; dos Santos RS; da-Silva WS; Almeida FC; Da Poian AT; Galina A
    Biochem J; 2009 Feb; 417(3):717-26. PubMed ID: 18945211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis.
    Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S
    Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani.
    Singh G; Dey CS
    Acta Trop; 2007 Sep; 103(3):172-85. PubMed ID: 17655815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.